Metaraminol
Adrenergic and Dopaminergic Agents
- Drug class
- Adrenergic and Dopaminergic Agents
- Availability
- See label
- Markets covered
- 1
- Products on record
- 9
Overview
Metaraminol is an active pharmaceutical ingredient in the Adrenergic and Dopaminergic Agents group (C01CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 9 | May 1, 2026 |
GBUnited Kingdom· MHRA
9 products
Uses
For the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and as an adjunct to accepted remedial procedures.
How to take
Drug interactions
Known interactions involving Metaraminol. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL144340042 · revised December 5, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.